Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
- Welireg
Descriptions
Belzutifan is used to treat von Hippel-Lindau (VHL) disease in patients who need treatment for kidney cancer (renal cell carcinoma), brain and spinal cord tumors (CNS hemangioblastomas), or pancreatic cancer (pancreatic neuroendocrine tumor [pNET]) that do not require surgery right away.
This medicine is available only with your doctor's prescription.
Portions of this document last updated: Sept. 01, 2021
Copyright © 2021 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.